Inventor

EIBL JOHANN

AT106 patents

⚠️ This page may combine multiple inventors who share the name “EIBL JOHANN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EIBL JOHANN

IMMUNO AG

Highly concentrated immunoglobulin preparation and method for its production

Arrangement for applying a tissue adhesive

Pharmaceutical preparation for treating blood coagulation disorders

Method for isolation of highly pure von Willebrand Factor

Thrombin and method of producing the same

Immunoglobulin-g-containing fraction

Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood products

Pharmaceutical preparation based on Lys-plasminogen

Use of von willebrand factor and pharmaceutical formulation

Stable preparation for the treatment of blood coagulation disorders

Preparation active against Pseudomonas aeruginosa infections and methods of producing them

Preparations active against pseudomonas aeruginosa infections and methods of producing them

Apparatus for performing a radioimmunological method of determining antigens or antibodies

Method for isolation of highly pure von willebrand factor

Thrombosis agent

Method for virus inactivation in the presence of polyalkylene glycol as well as the pharmaceutical preparation obtained therewith

Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen

Method of dissolving venous Thrombi using drug containing activated Protein C

Method of inactivating reproducible pathogens

Blood-coagulation-promoting preparation based on human proteins and a method of producing the same

Method of producing a blood-coagulation-promoting preparation from human blood plasma

Method of producing a virus-safe biological preparation

Method of producing a virus-safe biological preparation

Method of producing a factor VIII preparation

Method of inactivating reproducible filterable pathogens in blood plasma products

Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment

Method of determining the virus inactivation capacity of an inactivation treatment

BAXTER AG

Pharmaceutical preparation for treating blood coagulation disorders

Stable factor VIII/von Willebrand factor complex

Stable preparation for the treatment of blood coagulation disorders

Nucleic acids encoding factor X analogues having a modified protease cleavage site

Nucleic acids encoding factor X deletion mutants and analogues thereof

Method of recovering highly purified vWF or factor VIII/vWF-complex

Factor X analogues with a modified protease cleavage site

Factor X deletion mutants and analogues thereof

Purification of von-Willebrand factor by cation exchanger chromatography

Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence

Process for disintegrating nucleic acids and preparing biological products of guaranteed quality

Method for isolation of highly pure von willebrand factor

Prothrombin derivatives

Fibrinogen-based tissue adhesive containing an elastase inhibitor

Highly purified factor VIII complex

Factor VIII/vWF complexes and compositions

Pharmaceutical preparation for treating blood coagulation disorders

BIO PROD & BIO ENG AG

Method for the separation of recombinant pro-factor IX from recombinant factor IX

Adjuvant based on colloidal iron compounds

BUERMOOS DENTALWERK

Surgical handpiece

BIO PRODUCTS & BIO ENG AG

Elutriation chamber for an elutriator system

MAUTE MARKUS

Light emitting diode chip

BIO & BIO LICENSING SA

Pharmaceutical preparations and medicines capable of generating, and/or containing, thrombin